Home > > Europe And Global Veterinary Anti-infectives Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: EUROPE VETERINARY ANTI-INFECTIVES MARKET 3.1. OVERVIEW 3.2. EUROPE 3.2.1. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.2. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.3. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.4. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY COUNTRY 3.2.5.1. GERMANY 3.2.5.1.1. GERMANY VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.1.2. GERMANY VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.1.3. GERMANY VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.1.4. GERMANY VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.2. U.K. 3.2.5.2.1. U.K. VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.2.2. U.K. VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.2.3. U.K. VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.2.4. U.K. VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.3. FRANCE 3.2.5.3.1. FRANCE VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.3.2. FRANCE VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.3.3. FRANCE VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.3.4. FRANCE VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.4. ITALY 3.2.5.4.1. ITALY VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.4.2. ITALY VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.4.3. ITALY VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.4.4. ITALY VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.5. SPAIN 3.2.5.5.1. SPAIN VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.5.2. SPAIN VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.5.3. SPAIN VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.5.4. SPAIN VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.6. REST OF EUROPE 3.2.5.6.1. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.6.2. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.6.3. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.6.4. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL CHAPTER 4: GLOBAL VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 4.1. OVERVIEW 4.2. LIVESTOCK 4.2.1. LIVESTOCK MARKET, BY REGION 4.2.1.1. NORTH AMERICA LIVESTOCK MARKET, BY COUNTRY 4.2.1.2. EUROPE LIVESTOCK MARKET, BY COUNTRY 4.2.1.3. ASIA LIVESTOCK MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA LIVESTOCK MARKET, BY COUNTRY 4.3. COMPANION ANIMAL 4.3.1. COMPANION ANIMAL MARKET, BY REGION 4.3.1.1. NORTH AMERICA COMPANION ANIMAL MARKET, BY COUNTRY 4.3.1.2. EUROPE COMPANION ANIMAL MARKET, BY COUNTRY 4.3.1.3. ASIA COMPANION ANIMAL MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA COMPANION ANIMAL MARKET, BY COUNTRY CHAPTER 5: GLOBAL VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 5.1. OVERVIEW 5.2. ANTIBACTERIAL 5.2.1. ANTIBACTERIAL MARKET, BY REGION 5.2.1.1. NORTH AMERICA ANTIBACTERIAL MARKET, BY COUNTRY 5.2.1.2. EUROPE ANTIBACTERIAL MARKET, BY COUNTRY 5.2.1.3. ASIA ANTIBACTERIAL MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET, BY COUNTRY 5.3. ANTIFUNGALS 5.3.1. ANTIFUNGALS MARKET, BY REGION 5.3.1.1. NORTH AMERICA ANTIFUNGALS MARKET, BY COUNTRY 5.3.1.2. EUROPE ANTIFUNGALS MARKET, BY COUNTRY 5.3.1.3. ASIA ANTIFUNGALS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA ANTIFUNGALS MARKET, BY COUNTRY 5.4. ANTIVIRALS 5.4.1. ANTIVIRALS MARKET, BY REGION 5.4.1.1. NORTH AMERICA ANTIVIRALS MARKET, BY COUNTRY 5.4.1.2. EUROPE ANTIVIRALS MARKET, BY COUNTRY 5.4.1.3. ASIA ANTIVIRALS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA ANTIVIRALS MARKET, BY COUNTRY 5.5. OTHER PRODUCT TYPES 5.5.1. OTHER PRODUCT TYPES MARKET, BY REGION 5.5.1.1. NORTH AMERICA OTHER PRODUCT TYPES MARKET, BY COUNTRY 5.5.1.2. EUROPE OTHER PRODUCT TYPES MARKET, BY COUNTRY 5.5.1.3. ASIA OTHER PRODUCT TYPES MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA OTHER PRODUCT TYPES MARKET, BY COUNTRY CHAPTER 6: GLOBAL VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. ORAL 6.2.1. ORAL MARKET, BY REGION 6.2.1.1. NORTH AMERICA ORAL MARKET, BY COUNTRY 6.2.1.2. EUROPE ORAL MARKET, BY COUNTRY 6.2.1.3. ASIA ORAL MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA ORAL MARKET, BY COUNTRY 6.3. INJECTABLES 6.3.1. INJECTABLES MARKET, BY REGION 6.3.1.1. NORTH AMERICA INJECTABLES MARKET, BY COUNTRY 6.3.1.2. EUROPE INJECTABLES MARKET, BY COUNTRY 6.3.1.3. ASIA INJECTABLES MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA INJECTABLES MARKET, BY COUNTRY 6.4. OTHER ROUTE OF ADMINISTRATIONS 6.4.1. OTHER ROUTE OF ADMINISTRATIONS MARKET, BY REGION 6.4.1.1. NORTH AMERICA OTHER ROUTE OF ADMINISTRATIONS MARKET, BY COUNTRY 6.4.1.2. EUROPE OTHER ROUTE OF ADMINISTRATIONS MARKET, BY COUNTRY 6.4.1.3. ASIA OTHER ROUTE OF ADMINISTRATIONS MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA OTHER ROUTE OF ADMINISTRATIONS MARKET, BY COUNTRY CHAPTER 7: GLOBAL VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 7.1. OVERVIEW 7.2. VETERINARY CLINICS 7.2.1. VETERINARY CLINICS MARKET, BY REGION 7.2.1.1. NORTH AMERICA VETERINARY CLINICS MARKET, BY COUNTRY 7.2.1.2. EUROPE VETERINARY CLINICS MARKET, BY COUNTRY 7.2.1.3. ASIA VETERINARY CLINICS MARKET, BY COUNTRY 7.2.1.4. MIDDLE EAST & AFRICA VETERINARY CLINICS MARKET, BY COUNTRY 7.3. RETAIL PHARMACIES 7.3.1. RETAIL PHARMACIES MARKET, BY REGION 7.3.1.1. NORTH AMERICA RETAIL PHARMACIES MARKET, BY COUNTRY 7.3.1.2. EUROPE RETAIL PHARMACIES MARKET, BY COUNTRY 7.3.1.3. ASIA RETAIL PHARMACIES MARKET, BY COUNTRY 7.3.1.4. MIDDLE EAST & AFRICA RETAIL PHARMACIES MARKET, BY COUNTRY 7.4. E-COMMERCE 7.4.1. E-COMMERCE MARKET, BY REGION 7.4.1.1. NORTH AMERICA E-COMMERCE MARKET, BY COUNTRY 7.4.1.2. EUROPE E-COMMERCE MARKET, BY COUNTRY 7.4.1.3. ASIA E-COMMERCE MARKET, BY COUNTRY 7.4.1.4. MIDDLE EAST & AFRICA E-COMMERCE MARKET, BY COUNTRY TABLE 99. MIDDLE EAST & AFRICA E-COMMERCE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 02. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 05. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 07. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($MILLION) TABLE 08. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 09. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 10. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($MILLION) TABLE 11. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 12. GERMANY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 13. GERMANY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 14. GERMANY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 15. GERMANY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 16. U.K. VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 17. U.K. VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 18. U.K. VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 19. U.K. VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 20. FRANCE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 21. FRANCE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 22. FRANCE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 23. FRANCE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 24. ITALY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 25. ITALY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 26. ITALY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 27. ITALY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 28. SPAIN VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 29. SPAIN VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 30. SPAIN VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 31. SPAIN VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 32. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 33. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 34. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 35. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 36. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 37. LIVESTOCK MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 38. NORTH AMERICA LIVESTOCK MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. EUROPE LIVESTOCK MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. ASIA LIVESTOCK MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. MIDDLE EAST & AFRICA LIVESTOCK MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. COMPANION ANIMAL MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 43. NORTH AMERICA COMPANION ANIMAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. EUROPE COMPANION ANIMAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. ASIA COMPANION ANIMAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. MIDDLE EAST & AFRICA COMPANION ANIMAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 48. ANTIBACTERIAL MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 49. NORTH AMERICA ANTIBACTERIAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. EUROPE ANTIBACTERIAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. ASIA ANTIBACTERIAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. ANTIFUNGALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 54. NORTH AMERICA ANTIFUNGALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. EUROPE ANTIFUNGALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 56. ASIA ANTIFUNGALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. MIDDLE EAST & AFRICA ANTIFUNGALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. ANTIVIRALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 59. NORTH AMERICA ANTIVIRALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. EUROPE ANTIVIRALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. ASIA ANTIVIRALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. MIDDLE EAST & AFRICA ANTIVIRALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. OTHER PRODUCT TYPES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 64. NORTH AMERICA OTHER PRODUCT TYPES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. EUROPE OTHER PRODUCT TYPES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. ASIA OTHER PRODUCT TYPES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. MIDDLE EAST & AFRICA OTHER PRODUCT TYPES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 69. ORAL MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 70. NORTH AMERICA ORAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. EUROPE ORAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. ASIA ORAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. MIDDLE EAST & AFRICA ORAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. INJECTABLES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 75. NORTH AMERICA INJECTABLES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. EUROPE INJECTABLES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 77. ASIA INJECTABLES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 78. MIDDLE EAST & AFRICA INJECTABLES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 79. OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 80. NORTH AMERICA OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. EUROPE OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 82. ASIA OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 83. MIDDLE EAST & AFRICA OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 84. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 85. VETERINARY CLINICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 86. NORTH AMERICA VETERINARY CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 87. EUROPE VETERINARY CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 88. ASIA VETERINARY CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 89. MIDDLE EAST & AFRICA VETERINARY CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 90. RETAIL PHARMACIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 91. NORTH AMERICA RETAIL PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 92. EUROPE RETAIL PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 93. ASIA RETAIL PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 94. MIDDLE EAST & AFRICA RETAIL PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 95. E-COMMERCE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 96. NORTH AMERICA E-COMMERCE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 97. EUROPE E-COMMERCE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 98. ASIA E-COMMERCE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 99. MIDDLE EAST & AFRICA E-COMMERCE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: EUROPE VETERINARY ANTI-INFECTIVES MARKET 3.1. OVERVIEW 3.2. EUROPE 3.2.1. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.2. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.3. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.4. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5. EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY COUNTRY 3.2.5.1. GERMANY 3.2.5.1.1. GERMANY VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.1.2. GERMANY VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.1.3. GERMANY VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.1.4. GERMANY VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.2. U.K. 3.2.5.2.1. U.K. VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.2.2. U.K. VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.2.3. U.K. VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.2.4. U.K. VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.3. FRANCE 3.2.5.3.1. FRANCE VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.3.2. FRANCE VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.3.3. FRANCE VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.3.4. FRANCE VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.4. ITALY 3.2.5.4.1. ITALY VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.4.2. ITALY VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.4.3. ITALY VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.4.4. ITALY VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.5. SPAIN 3.2.5.5.1. SPAIN VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.5.2. SPAIN VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.5.3. SPAIN VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.5.4. SPAIN VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 3.2.5.6. REST OF EUROPE 3.2.5.6.1. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 3.2.5.6.2. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 3.2.5.6.3. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 3.2.5.6.4. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL CHAPTER 4: GLOBAL VETERINARY ANTI-INFECTIVES MARKET, BY ANIMAL TYPE 4.1. OVERVIEW 4.2. LIVESTOCK 4.2.1. LIVESTOCK MARKET, BY REGION 4.2.1.1. NORTH AMERICA LIVESTOCK MARKET, BY COUNTRY 4.2.1.2. EUROPE LIVESTOCK MARKET, BY COUNTRY 4.2.1.3. ASIA LIVESTOCK MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA LIVESTOCK MARKET, BY COUNTRY 4.3. COMPANION ANIMAL 4.3.1. COMPANION ANIMAL MARKET, BY REGION 4.3.1.1. NORTH AMERICA COMPANION ANIMAL MARKET, BY COUNTRY 4.3.1.2. EUROPE COMPANION ANIMAL MARKET, BY COUNTRY 4.3.1.3. ASIA COMPANION ANIMAL MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA COMPANION ANIMAL MARKET, BY COUNTRY CHAPTER 5: GLOBAL VETERINARY ANTI-INFECTIVES MARKET, BY PRODUCT TYPE 5.1. OVERVIEW 5.2. ANTIBACTERIAL 5.2.1. ANTIBACTERIAL MARKET, BY REGION 5.2.1.1. NORTH AMERICA ANTIBACTERIAL MARKET, BY COUNTRY 5.2.1.2. EUROPE ANTIBACTERIAL MARKET, BY COUNTRY 5.2.1.3. ASIA ANTIBACTERIAL MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET, BY COUNTRY 5.3. ANTIFUNGALS 5.3.1. ANTIFUNGALS MARKET, BY REGION 5.3.1.1. NORTH AMERICA ANTIFUNGALS MARKET, BY COUNTRY 5.3.1.2. EUROPE ANTIFUNGALS MARKET, BY COUNTRY 5.3.1.3. ASIA ANTIFUNGALS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA ANTIFUNGALS MARKET, BY COUNTRY 5.4. ANTIVIRALS 5.4.1. ANTIVIRALS MARKET, BY REGION 5.4.1.1. NORTH AMERICA ANTIVIRALS MARKET, BY COUNTRY 5.4.1.2. EUROPE ANTIVIRALS MARKET, BY COUNTRY 5.4.1.3. ASIA ANTIVIRALS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA ANTIVIRALS MARKET, BY COUNTRY 5.5. OTHER PRODUCT TYPES 5.5.1. OTHER PRODUCT TYPES MARKET, BY REGION 5.5.1.1. NORTH AMERICA OTHER PRODUCT TYPES MARKET, BY COUNTRY 5.5.1.2. EUROPE OTHER PRODUCT TYPES MARKET, BY COUNTRY 5.5.1.3. ASIA OTHER PRODUCT TYPES MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA OTHER PRODUCT TYPES MARKET, BY COUNTRY CHAPTER 6: GLOBAL VETERINARY ANTI-INFECTIVES MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. ORAL 6.2.1. ORAL MARKET, BY REGION 6.2.1.1. NORTH AMERICA ORAL MARKET, BY COUNTRY 6.2.1.2. EUROPE ORAL MARKET, BY COUNTRY 6.2.1.3. ASIA ORAL MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA ORAL MARKET, BY COUNTRY 6.3. INJECTABLES 6.3.1. INJECTABLES MARKET, BY REGION 6.3.1.1. NORTH AMERICA INJECTABLES MARKET, BY COUNTRY 6.3.1.2. EUROPE INJECTABLES MARKET, BY COUNTRY 6.3.1.3. ASIA INJECTABLES MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA INJECTABLES MARKET, BY COUNTRY 6.4. OTHER ROUTE OF ADMINISTRATIONS 6.4.1. OTHER ROUTE OF ADMINISTRATIONS MARKET, BY REGION 6.4.1.1. NORTH AMERICA OTHER ROUTE OF ADMINISTRATIONS MARKET, BY COUNTRY 6.4.1.2. EUROPE OTHER ROUTE OF ADMINISTRATIONS MARKET, BY COUNTRY 6.4.1.3. ASIA OTHER ROUTE OF ADMINISTRATIONS MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA OTHER ROUTE OF ADMINISTRATIONS MARKET, BY COUNTRY CHAPTER 7: GLOBAL VETERINARY ANTI-INFECTIVES MARKET, BY DISTRIBUTION CHANNEL 7.1. OVERVIEW 7.2. VETERINARY CLINICS 7.2.1. VETERINARY CLINICS MARKET, BY REGION 7.2.1.1. NORTH AMERICA VETERINARY CLINICS MARKET, BY COUNTRY 7.2.1.2. EUROPE VETERINARY CLINICS MARKET, BY COUNTRY 7.2.1.3. ASIA VETERINARY CLINICS MARKET, BY COUNTRY 7.2.1.4. MIDDLE EAST & AFRICA VETERINARY CLINICS MARKET, BY COUNTRY 7.3. RETAIL PHARMACIES 7.3.1. RETAIL PHARMACIES MARKET, BY REGION 7.3.1.1. NORTH AMERICA RETAIL PHARMACIES MARKET, BY COUNTRY 7.3.1.2. EUROPE RETAIL PHARMACIES MARKET, BY COUNTRY 7.3.1.3. ASIA RETAIL PHARMACIES MARKET, BY COUNTRY 7.3.1.4. MIDDLE EAST & AFRICA RETAIL PHARMACIES MARKET, BY COUNTRY 7.4. E-COMMERCE 7.4.1. E-COMMERCE MARKET, BY REGION 7.4.1.1. NORTH AMERICA E-COMMERCE MARKET, BY COUNTRY 7.4.1.2. EUROPE E-COMMERCE MARKET, BY COUNTRY 7.4.1.3. ASIA E-COMMERCE MARKET, BY COUNTRY 7.4.1.4. MIDDLE EAST & AFRICA E-COMMERCE MARKET, BY COUNTRY TABLE 01. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 02. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 05. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 07. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($MILLION) TABLE 08. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($MILLION) TABLE 09. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 10. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($MILLION) TABLE 11. EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 12. GERMANY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 13. GERMANY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 14. GERMANY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 15. GERMANY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 16. U.K. VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 17. U.K. VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 18. U.K. VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 19. U.K. VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 20. FRANCE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 21. FRANCE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 22. FRANCE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 23. FRANCE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 24. ITALY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 25. ITALY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 26. ITALY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 27. ITALY VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 28. SPAIN VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 29. SPAIN VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 30. SPAIN VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 31. SPAIN VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 32. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 33. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 34. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 35. REST OF EUROPE VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 36. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ANIMAL TYPE, 2023-2030, ($ MILLION) TABLE 37. LIVESTOCK MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 38. NORTH AMERICA LIVESTOCK MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. EUROPE LIVESTOCK MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. ASIA LIVESTOCK MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. MIDDLE EAST & AFRICA LIVESTOCK MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. COMPANION ANIMAL MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 43. NORTH AMERICA COMPANION ANIMAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. EUROPE COMPANION ANIMAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. ASIA COMPANION ANIMAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. MIDDLE EAST & AFRICA COMPANION ANIMAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY PRODUCT TYPE, 2023-2030, ($ MILLION) TABLE 48. ANTIBACTERIAL MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 49. NORTH AMERICA ANTIBACTERIAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. EUROPE ANTIBACTERIAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. ASIA ANTIBACTERIAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. MIDDLE EAST & AFRICA ANTIBACTERIAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. ANTIFUNGALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 54. NORTH AMERICA ANTIFUNGALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. EUROPE ANTIFUNGALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 56. ASIA ANTIFUNGALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. MIDDLE EAST & AFRICA ANTIFUNGALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. ANTIVIRALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 59. NORTH AMERICA ANTIVIRALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. EUROPE ANTIVIRALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. ASIA ANTIVIRALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. MIDDLE EAST & AFRICA ANTIVIRALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. OTHER PRODUCT TYPES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 64. NORTH AMERICA OTHER PRODUCT TYPES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. EUROPE OTHER PRODUCT TYPES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. ASIA OTHER PRODUCT TYPES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. MIDDLE EAST & AFRICA OTHER PRODUCT TYPES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 69. ORAL MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 70. NORTH AMERICA ORAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. EUROPE ORAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. ASIA ORAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. MIDDLE EAST & AFRICA ORAL MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. INJECTABLES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 75. NORTH AMERICA INJECTABLES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. EUROPE INJECTABLES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 77. ASIA INJECTABLES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 78. MIDDLE EAST & AFRICA INJECTABLES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 79. OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 80. NORTH AMERICA OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. EUROPE OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 82. ASIA OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 83. MIDDLE EAST & AFRICA OTHER ROUTE OF ADMINISTRATIONS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 84. GLOBAL VETERINARY ANTI-INFECTIVES MARKET VALUE, BY DISTRIBUTION CHANNEL, 2023-2030, ($ MILLION) TABLE 85. VETERINARY CLINICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 86. NORTH AMERICA VETERINARY CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 87. EUROPE VETERINARY CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 88. ASIA VETERINARY CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 89. MIDDLE EAST & AFRICA VETERINARY CLINICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 90. RETAIL PHARMACIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 91. NORTH AMERICA RETAIL PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 92. EUROPE RETAIL PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 93. ASIA RETAIL PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 94. MIDDLE EAST & AFRICA RETAIL PHARMACIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 95. E-COMMERCE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 96. NORTH AMERICA E-COMMERCE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 97. EUROPE E-COMMERCE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 98. ASIA E-COMMERCE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 99. MIDDLE EAST & AFRICA E-COMMERCE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)